InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the detailed record of transactions filed by Erlander Mark. Officer active across 1 company, notably Cardiff Oncology, Inc.. Aggregated, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €14k. History available since 25 November 2022. The latest transaction was filed on 25 November 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration